DWM
BIO icon

Dakota Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Dakota Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,281
Closed -$459K – 664
2023
Q3 		$459K Sell
1,281
-7
-0.5% -$2.7K 0.02% 425
2023
Q2 		$488K Sell
1,288
-59
-4% -$24K 0.02% 390
2023
Q1 		$645K Buy
1,347
+70
+5% +$32.8K 0.04% 308
2022
Q4 		$537K Buy
1,277
+217
+20% +$87.6K 0.04% 340
2022
Q3 		$443K Buy
1,060
+270
+34% +$135K 0.04% 356
2022
Q2 		$391K Buy
+790
New +$411K 0.04% 322

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return